Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order ...
In this study, we aimed to quantify the impact of data-driven motion-correction reconstruction for PET imaging on still and motion-corrupted 18F-FDG PET brain scans of children and adolescents.
The growing demand for amyloid and tau PET imaging, driven by new dementia therapies and biomarker-based diagnosis, has increased the need for accessible PET brain imaging in outpatient neurology ...
The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...
Neurodegenerative diseases are characterized by progressive neuronal dysfunction, synaptic loss, and decline in cognitive, behavioral, or motor function. Understanding these disorders requires a ...
PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape ...
The past year has marked a period of significant growth, collaboration, and strategic investment for the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS), with a ...
Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...
We report the cases of 3 patients with biopsy-proven light-chain cardiac amyloidosis (AL-CA) presenting with varying clinical manifestations and abnormal findings on Tc-based bone-avid scintigraphy, ...
(A) Myocardial perfusion scan demonstrates typical mild fixed inferior wall perfusion abnormality (arrowheads) in male patient resulting from diaphragmatic attenuation. (B) Quantitative analysis using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results